CORDRAN .5 mg/g
Flurandrenolide · CREAM · INA Pharmaceutics, Inc
CORDRAN is a cream containing flurandrenolide at .5 mg/g, taken topical. Manufactured by INA Pharmaceutics, Inc.
Key Facts
- Brand Name
- CORDRAN
- Generic Name
- Flurandrenolide
- NDC Code (Product)
74157-130- Manufacturer
- INA Pharmaceutics, Inc
- Strength
- .5 mg/g
- Dosage Form
- CREAM
- Route
- TOPICAL
- Marketing Status
- Application #
- NDA012806
- Drug Class
- Corticosteroid [EPC]
- Marketing Start
- 07/07/2025
Recall History
No Recall HistorySide Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
Full Prescribing Information
Indications & Usage
INDICATIONS AND USAGE Cordran® (flurandrenolide, USP) is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
Dosage & Administration
DOSAGE AND ADMINISTRATION For moist lesions, a small quantity of the cream should be rubbed gently into the affected areas 2 or 3 times a day. Therapy should be discontinued when control is achieved. If no improvement is seen within 2 weeks, reassessment of the diagnosis may be necessary. Cordran® (flurandrenolide, USP) should not be used with occlusive dressings unless directed by a physician. Tight-fitting diapers or plastic pants may constitute occlusive dressings.
Contraindications
CONTRAINDICATIONS Topical corticosteroids are contraindicated in patients with a history of hypersensitivity to any of the components of these preparations.
Adverse Reactions
ADVERSE REACTIONS The following local adverse reactions are reported infrequently with topical corticosteroids but may occur more frequently with the use of occlusive dressings. These reactions are listed in an approximate decreasing order of occurrence: Burning Itching Irritation Dryness Folliculitis Hypertrichosis Acneform eruptions Hypopigmentation Perioral dermatitis Allergic contact dermatitis The following may occur more frequently with occlusive dressings: Maceration of the skin Secondary infection Skin atrophy Striae Miliaria Postmarketing Adverse Reactions The following adverse reactions have been identified during post approval use of flurandrenolide, USP. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure. Skin : skin striae, hypersensitivity, skin atrophy, contact dermatitis and skin discoloration.
Frequently Asked Questions
What is CORDRAN used for?
CORDRAN contains Flurandrenolide. It is a cream taken topical. Consult your doctor for specific uses.
Is CORDRAN a controlled substance?
CORDRAN is not classified as a controlled substance by the DEA.
What is the generic name for CORDRAN?
The generic name for CORDRAN is Flurandrenolide. There are 3 other brand versions of Flurandrenolide.
What is the NDC code for CORDRAN .5 mg/g?
The NDC (National Drug Code) for CORDRAN .5 mg/g is 74157-130, listed by INA Pharmaceutics, Inc.